| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | 0.24 | 0.09 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.09 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.05 | 0.09 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.049 | 0.09 |
| mRNA | Pazopanib | FIMM | pan-cancer | AAC | -0.3 | 0.09 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.09 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.082 | 0.09 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.059 | 0.09 |